References
- Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine 2000; 79(4): 201–9.
- Jaunay E, Gaillac V, Guelfi JD. Serotonin syndrome. Which treatment and when? Presse Med 2001; 30(34): 1695–700.
- Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13(1): 100–9.
- Bijl D. The serotonin syndrome. Neth J Med 2004; 62(9): 309–13.
- Bellakhdar J. La pharmacopee marocaine traditionnelle, Paris: Medecine arabe ancienne et savoirs populaires; 2008. p. 529–30.
- Sincich F. Bedouin traditional medicine in the Syrian Steppe. Rome: FAO; 2002. p.114–5.
- Dymock W, Warden CJH, Hooper D. Pharmacopia Indica. Harmard National Foundation of Pakistan, 1976; 1:252–3.
- Kim H, Sablin SO, Ramsay RR. Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys 1997; 337(1): 137–42.
- Iurlo M, Leone G, Schilström B, Linnér L, Nomikos G, Hertel P, et al. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition. Psychopharmacology 2001; 159(1): 98–104.
- Herraiz T, Guillen H, Arán VJ. Oxidative metabolism of the bioactive and naturally occuring beta-carboline alkaloids, norharman and harman, by human cytochrome P450 enzymes. Chem Res Toxicol 2008; 21(11): 2172–80.
- Parker CA, Anderson NJ, Robinson ES, Price R, Tyacke RJ, Husbands SM, et al. Harmane and harmalan are bioactive components of classical clonidine-displacing substance. Biochemistry 2004; 43(51): 16385–92.
- Rotblatt M, Ziment I. Evidence-based herbal medicine. Philadelphia, PA: Hanley & Belfus Inc; 2002.
- Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int 2011; 108(41): 687–93.
- Mahmoudian M, Jalilpour H, Salehian P. Toxicity of Peganum harmala: Review and a case report. Iran J Pharmacol Ther 2002; 1: 1–4.
- Zhao T, He YQ, Wang J, Ding KM, Wang CH, Wang ZT. Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by ß-carboline alkaloids, harmine derivatives. Phytother Res 2011; 25(11): 1671–7.
- Allard S, Sainati S, Roth-Schechter B, MacIntyre J. Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women. Drug Metab Dispos 1998; 26(7): 617–22.
- McDaniel WW. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother 2001; 35(7–8): 870–3.